Your privacy is very important to us.When you visit our website,please agree to the use of all cookies.For more information about personal data processing,please go to Privacy Statement.

  • d1banner01.jpg d1banner01ph.jpg

    Pipeline

Pipeline

Nuance is co-developing global leading innovative pipeline portfolio with FIC respiratory candidates, targeting innovative specialty therapies with high potential, high entry barrier, multi synergy and reasonable competition

Respiratory

Pain Management

Emergency Care

Iron Deficiency Anemia

Asset

Indications

Pre-clinical

Phase 1

Phase 2

Phase 3

Approval

Territory

Ensifentrine

(Verona)

COPD

China mainland, HK, Macau, Taiwan

AerofactTM

(Aerogen)

Respiratory distress syndrome (RDS)

China mainland, HK, Macau, Taiwan

BentrioTM

(Altamira)

Allergy alleviation/virus prevention nasal spray

China mainland, HK, Macau, Korea

NTM-001

(Neumentum)

POP (post operative pain) 24 hours

China mainland, HK, Macau, Taiwan

ISOKET

(Injectable)

Heart failure, angina, myocardial infarction

China mainland

ISOKET

(Spray)

Heart failure, angina, myocardial infarction

China mainland

ELANTAN

Heart failure, CHD, angina

China mainland

OPRINONE

Heart failure

China mainland

NIFEREX

Iron deficiency anemia

Asia Pac - Trademark across multiple territories

Ensifentrine

(Verona)

COPD

Pre-clinical

Phase 1

Phase 2

Phase 3

Approval

China mainland, HK, Macau, Taiwan

AerofactTM

(Aerogen)

Respiratory distress syndrome (RDS)

Pre-clinical

Phase 1

Phase 2

Phase 3

Approval

China mainland, HK, Macau, Taiwan

BentrioTM

(Altamira)

Allergy alleviation/virus prevention nasal spray

Pre-clinical

Phase 1

Phase 2

Phase 3

Approval

China mainland, HK, Macau, Korea

NTM-001

(Neumentum)

POP (post operative pain) 24 hours

Pre-clinical

Phase 1

Phase 2

Phase 3

Approval

China mainland, HK, Macau, Taiwan

ISOKET

(Injectable)

Heart failure, angina, myocardial infarction

Pre-clinical

Phase 1

Phase 2

Phase 3

Approval

China mainland

ISOKET

(Spray)

Heart failure, angina, myocardial infarction

Pre-clinical

Phase 1

Phase 2

Phase 3

Approval

China mainland

ELANTAN

Heart failure, CHD, angina

Pre-clinical

Phase 1

Phase 2

Phase 3

Approval

China mainland

OPRINONE

Heart failure

Pre-clinical

Phase 1

Phase 2

Phase 3

Approval

China mainland

NIFEREX

Iron deficiency anemia

Pre-clinical

Phase 1

Phase 2

Phase 3

Approval

Asia Pac - Trademark across multiple territories

CONTACT

Suite 639, East Tower, No 1376 Nan Jing West Road, Shanghai. 200040

Copyright 2023 NUANCE BIOTECH reserved. 沪ICP备17029781号-4